SCHEMBL5763404

SCHEMBL5763404

CC(C#N)N(C)C(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2654969 0.75 DPP4 (0.52)
SCHEMBL7454779 0.73 DPP4 (0.39)
SCHEMBL19385618 0.73
SCHEMBL7051119 0.73 DPP4 (0.46)
SCHEMBL2813812 0.73 DPP4 (0.46)
SCHEMBL2379773 0.71 DPP4 (0.44)
SCHEMBL7176203 0.70 DPP4 (0.51)
SCHEMBL21813955 0.70 DPP4 (0.36)
SCHEMBL21813950 0.70 DPP4 (0.36)
Propionic Acid SCHEMBL15523153 0.70 FFAR3 (0.43)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1506193-B9 CARBAMATE-SUBSTITUTED PYRAZOLOPYRIDINES ADVERIO PHARMA GMBH (DE) 2026-02-18 EP disclosed
EP-1506193-B3 CARBAMATE-SUBSTITUTED PYRAZOLOPYRIDINES ADVERIO PHARMA GMBH (DE) 2025-12-03 EP disclosed
CN-112679373-B Environment-friendly clean production process of D, L-alanine 天宝动物营养科技股份有限公司 2023-07-21 CN disclosed
EP-1682182-A1 NOVEL COMBINATION CONTAINING A STIMULATOR OF SOLUBLE GUANYLATE CYCLASE AND A LIPID-LOWERING SUBSTANCE Bayer HealthCare AG (DE) 2006-07-26 EP disclosed
EP-1506193-B1 CARBAMATE-SUBSTITUTED PYRAZOLOPYRIDINES BAYER HEALTHCARE AG (DE) 2006-06-21 EP disclosed
WO-2005046725-A1 NOVEL COMBINATION CONTAINING A STIMULATOR OF SOLUBLE GUANYLATE CYCLASE AND A LIPID-LOWERING SUBSTANCE BAYER HEALTHCARE AG (DE) 2005-05-26 WO disclosed
EP-1506193-A1 CARBAMATE-SUBSTITUTED PYRAZOLOPYRIDINES Bayer HealthCare AG (DE) 2005-02-16 EP disclosed
WO-2003095451-A1 CARBAMATE-SUBSTITUTED PYRAZOLOPYRIDINES BAYER HEALTHCARE AG (DE) 2003-11-20 WO disclosed